YAYusuf Adelabu

Yusuf Adelabu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yusuf Adelabu has a total of 89 co-authors. Here are the top co-authors by number of shared publications:

  • Aduragbemi Banke-Thomas

    School of Human Sciences, University of Greenwich, London, United Kingdom

    3 shared publications
  • Bosede Bukola Afolabi

    Department of Obstetrics and Gynaecology, University of Lagos College of Medicine, Lagos, Nigeria

    3 shared publications
  • Ejemai Eboreime

    Dalhousie University

    3 shared publications
  • Mobolanle Balogun

    Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK

    3 shared publications
  • Aduragbemi Banke-Thomas

    Affiliations Centre for Clinical Trials and Implementation Science (CCTRIS), College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria, Maternal, Adolescent, Reproductive and Child Health (MARCH), Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom

    2 shared publications
  • Bosede B. Afolabi

    Affiliations Centre for Clinical Trials, Research and Implementation Science, University of Lagos, Lagos, Nigeria, Department of Obstetrics and Gynaecology, Lagos University Teaching Hospital, Lagos, Nigeria

    2 shared publications

Latest Publications

  • Open Access

    Implementing intravenous iron for maternal anemia in Nigeria: A qualitative study of healthcare provider experiences using the normalization process theory

    by Damilola Onietan, Chisom Obi‑Jeff, Yusuf Adelabu, Mobolanle Balogun, Opeyemi Akinajo, Esther O. Oluwole, Aduragbemi Banke‑Thomas, Bosede B. Afolabi, Ejemai Eboreime

    Background: Maternal anemia remains a significant public health challenge in Nigeria, affecting approximately 25–46% of pregnant women and contributing to adverse maternal and neonatal outcomes. Intravenous (IV) iron provides a promising alternative to conventional oral iron supplementation for managing moderate to severe maternal anemia; however, its implementation in resource-limited settings faces numerous challenges. This study aimed to understand how the implementation of IV iron became embedded in everyday practice, including factors influencing skilled healthcare providers’ (SHPs) engagement, workflow integration processes, and sustainability. Methods: This was a qualitative study embedded within the Implementation Research for Intravenous Iron Use in Pregnant and Postpartum Women in Nigeria (IVON-IS) project across six healthcare facilities in Lagos, Nigeria. Eighteen key informant interviews were conducted with purposively sampled SHPs across the six IVON-IS facilities. The data were analyzed deductively based on the Normalization Process Theory (NPT) constructs (coherence, cognitive participation, collective action, and reflexive monitoring), and inductively to identify themes related to each of these constructs. Results: Our study revealed strong coherence among SHPs regarding the purpose and benefits of IV iron compared to traditional treatments. Cognitive participation varied across facilities, with leadership support and patient-centred motivation emerging as critical facilitators. Collective action was faced with challenges, including workflow disruptions, staffing constraints, and space limitations, despite adequate resource provision. Reflexive monitoring processes were robust, with providers continuously evaluating effectiveness through clinical outcomes and patient feedback while expressing concerns about long-term sustainability. Conclusion: The implementation of IV iron for maternal anemia in Nigeria demonstrated variability across NPT constructs, with strong coherence and reflexive monitoring but challenges in cognitive participation and collective action. Critical success factors included strong leadership support, adequate resource provision, continuous quality improvement processes, and proactive sustainability planning. The findings from this study provide valuable guidance for scaling up IV iron use as part of comprehensive maternal health services in Nigeria and similar resource-constrained settings.


  • Open Access

    Intravenous iron for anaemia in pregnancy: A quantitative study of acceptability and feasibility of its integration into routine antenatal care practice in Nigeria

    by Opeyemi Rebecca Akinajo, Aduragbemi Banke-Thomas, Kristi Sidney Annerstedt, Lenka Beňová, Yusuf Adetomiwa Adelabu, Nadia Adjoa Sam-Agudu, Bosede Bukola Afolabi

    Background: Anaemia in pregnancy (AIP), defined as a haemoglobin concentration of less than 11g/dl, is a significant global health issue, especially in resource-constrained settings. Of all the causes of AIP, iron deficiency anaemia is the commonest, accounting for approximately half of cases. While oral iron treatment is standard according to the WHO recommendation, poor adherence is a concern. Intravenous (IV) iron is an alternative treatment, especially in cases where oral iron is challenging to utilise. However, this intervention is yet to be integrated into routine antenatal care. This study aimed to assess skilled health personnels' (SHPs) perceptions of the acceptability and feasibility of IV iron in managing AIP in Lagos and Kano based on SHP characteristics and changes over time. Methods: This was a repeated cross-sectional study embedded within a randomised controlled trial (RCT) conducted in 11 healthcare facilities in Lagos and Kano states, Nigeria. All SHPs trained in implementing IV iron were invited to participate in the study. Data were collected using the Acceptability and Feasibility of Intervention measure (AIM and FIM) survey tools between the RCT baseline in August 2021 and the endline in May 2023. Analysis was done using descriptive statistics, independent and Paired T-tests and Analysis of variance (ANOVA) in Stata. Results: Of the 60 SHPs invited at baseline (pre-implementation), 53 (88%) completed the survey. At endline (post-implementation), 39 of the 46 SHPs involved in IV iron implementation responded (85%). When comparing groups, baseline AIM scores differed significantly by state ( p = 0.001), though this was not sustained at endline. No other significant differences were seen by cadre or facility for AIM, and FIM did not differ significantly by state, cadre, or facility at either time point. Among the 20 SHPs who completed both surveys, the AIM score increased from baseline 16.8/20 (Standard deviation, SD = 2.0) to endline (18.5, SD = 2.0) ( p = 0.002). FIM scores also increased over time, 17.1/20 (SD = 2.3) versus 18.2/20 (SD = 1.7) ( p = 0.088). Conclusion: Post-implementation, IV iron was perceived as highly acceptable and feasible with no differences across cadre, state, or facility levels. While acceptability significantly improved over time, feasibility also increased, though not statistically significantly at the 0.05 level.


  • Open Access

    Implementation of Routine Screening Practices for Pregnancy‐Related Anaemia: A Scoping Review

    by Yusuf Adelabu, Iana Malasevskaia, Mobolanle Balogun, Victoria Adaramoye, Lenka Benova, Bosede Afolabi, Aduragbemi Banke-Thomas

    Background: Screening for anaemia in pregnancy and the postpartum period is an important component of maternal care to prevent associated morbidity and mortality. However, the implementation of routine screening practices for pregnancy‐related anaemia remains variable, inconsistent, and suboptimal. This review aimed to synthesise the literature on practices, facilitators, barriers, implementation strategies, and outcomes of routine screening for pregnancy‐related anaemia. Methods: This scoping review followed the JBI methodology and PRISMA‐ScR checklist with a comprehensive systematic search of seven academic databases (PubMed, EMBASE, Scopus, CINAHL, Web of Science, Global Index Medicus, and African Journals Online) and selected grey literature sources. Retrieved citations were screened, and relevant references were assessed for eligibility. Articles included were analysed qualitatively and presented descriptively by concept, comparing settings with high and low prevalence of anaemia in pregnancy. Results: We identified 9497 references and included 116 articles in this review. Clinical practice guidelines recommend universal screening for anaemia during pregnancy and selective screening in the postpartum period using automated or point‐of‐care haemoglobin testing and iron studies, with variations in screening frequency and timing. Screening coverage for anaemia in pregnancy was lower in high‐prevalence compared to low‐prevalence settings. Effective supportive supervision was the main facilitator of anaemia screening in pregnancy, while lack of screening materials served as the main barrier, particularly in high‐prevalence settings. Training health workers on point‐of‐care testing in high‐prevalence settings was the most common strategy used to improve the implementation of routine screening for anaemia in pregnancy, and its feasibility was the most studied implementation outcome. Conclusion: Implementing routine screening practices for pregnancy‐related anaemia in all settings will benefit from harmonised clinical practice guidelines. Efforts are required to address implementation challenges and move from the early phase of implementation towards sustainability. Future research should aim to fill the knowledge gaps in implementing anaemia screening, particularly in the postpartum period.

  • Open Access

    Integrating a single-dose intravenous iron therapy (ferric carboxymaltose) for maternal anaemia in Nigeria: Insights from stakeholder engagement

    by Rachel A. Thompson, Uchenna Gwacham-Anisiobi, Chisom Obi-Jeff, Mobolanle Balogun, Opeyemi R. Akinajo, Esther Oluwole, Yusuf Adelabu, Temitope Audu, Bosede B. Afolabi, Aduragbemi Banke-Thomas

    Background: Maternal anaemia contributes to high maternal morbidity and adverse birth outcomes in Nigeria. Oral iron supplementation is common but limited by poor adherence, side effects and systemic barriers. Ferric carboxymaltose (FCM), a single-dose intravenous iron formulation, offers a promising alternative, yet its routine use in Nigeria remains limited. Policymakers, providers and community leaders influence adoption of health services, making their perspectives key to successful integration. Aim: To explore stakeholder perspectives on integrating FCM for maternal anaemia into routine maternal health services. Setting: The study was conducted in Lagos State, Nigeria. Methods: A qualitative descriptive study was conducted. Thirty-three purposively selected stakeholders participated, representing government agencies, healthcare providers, academic institutions, non-governmental organisations, professional associations and community leaders. Participants were grouped by affiliation and roles to encourage open dialogue. Discussions followed a semi-structured guide, were audio-recorded, transcribed verbatim and thematically analysed using an inductive approach. Results: Three interrelated themes emerged: (1) health workers are not sufficiently prepared for intravenous iron delivery but could be through sensitisation, reorientation and resourcing; (2) sociocultural and religious influences, alongside misconceptions, require targeted community engagement and (3) affordability is a barrier but could be addressed through strategic policy levers. Conclusion: Successful integration of FCM requires investment in health system capacity, sustained community engagement and alignment with financing and policy frameworks. Contribution: The findings illustrate how stakeholder-informed analysis can reveal the practical, cultural and financial conditions necessary for sustainable uptake of FCM, advancing understanding of how maternal health innovations can be integrated within fragmented health systems.

  • Open Access

    Implementing intravenous iron for maternal anemia in Nigeria: A qualitative study of healthcare provider experiences using the Normalization Process Theory

    by Damilola Onietan, Chisom Obi-Jeff, Yusuf Adelabu, Mobolanle Balogun, Opeyemi Akinajo, Esther O. Oluwole, Aduragbemi Banke-Thomas, Bosede B. Afolabi, Ejemai Eboreime

    Background: Maternal anemia remains a significant public health challenge in Nigeria, affecting approximately 25-46% of pregnant women and contributing to adverse maternal and neonatal outcomes. Intravenous (IV) iron provides a promising alternative to conventional oral iron supplementation for managing moderate to severe maternal anemia; however, its implementation in resource-limited settings faces numerous challenges. This study aimed to understand how the implementation of IV iron became embedded in everyday practice, including factors influencing skilled healthcare providers’ (SHPs) engagement, workflow integration processes, and sustainability. Methods: This was a qualitative study embedded within the Implementation Research for Intravenous Iron Use in Pregnant and Postpartum Women in Nigeria (IVON-IS) project across six healthcare facilities in Lagos, Nigeria. Eighteen key informant interviews were conducted with purposively sampled SHPs across the six IVON-IS facilities. The data were analyzed deductively based on the Normalization Process Theory (NPT) constructs (coherence, cognitive participation, collective action, and reflexive monitoring), and inductively to identify themes related to each of these constructs. Results: Our study revealed strong coherence among SHPs regarding the purpose and benefits of IV iron compared to traditional treatments. Cognitive participation varied across facilities, with leadership support and patient-centred motivation emerging as critical facilitators. Collective action was faced with challenges, including workflow disruptions, staffing constraints, and space limitations, despite adequate resource provision. Reflexive monitoring processes were robust, with providers continuously evaluating effectiveness through clinical outcomes and patient feedback while expressing concerns about long-term sustainability. Conclusion: The implementation of IV iron for maternal anemia in Nigeria demonstrated variability across NPT constructs, with strong coherence and reflexive monitoring but challenges in cognitive participation and collective action. Critical success factors included strong leadership support, adequate resource provision, continuous quality improvement processes, and proactive sustainability planning. These findings provide valuable guidance for scaling up IV iron use as part of comprehensive maternal health services in Nigeria and similar resource-constrained settings.

  • Open Access

    Air Pollution and Pediatric Central Nervous Tumors: A Systematic Review of Evidence and Public Health Implications

    by Nantawan Koonalinthip, Rogerio Diniz Takahashi, São Paulo Centro de Diagnósticos Brasil - Alliança Saúde, Tatiana Soares, Jose Gabriel Lara-Amador, Ramiro Sienra, São José dos Campos Centro de Oncologia e Doenças Autoimunes, Pilar Buendía Montenegro, Hospital del Trabajador Acute Pain Unit, Maria Daniela Sarquis, et al.

    Background: Exposure to environmental pollution, particularly air pollutants, and its relationship with childhood central nervous system (CNS) tumors is a growing public health concern. Understanding these associations is crucial for the implementation of protective measures for children and the development of strategic public policies. Objective: This systematic review examines the association between air pollution exposure and the risk of CNS tumors in the pediatric population aged 0-19 years. Methods: Following PRISMA guidelines, we used PubMed, SCOPUS, EMBASE, Google Scholar, and CENTRAL baselines up to May 2024. We included only observational studies focusing on children exposed to air pollutants, excluding tobacco-related exposures. Data on study design, population characteristics, exposure assessment, and types of CNS tumors were extracted and analyzed. Results: We included 25 studies (case-control and cohort) conducted across North America, Europe, Australia, and Asia. The studies assessed pollutants such as benzene, nitrogen dioxide (NO2), particulate matter (PM2.5), and polycyclic aromatic hydrocarbons (PAHs). Some studies reported positive associations between specific pollutants and increased CNS tumor risk, while others found no significant links. Variability in exposure assessment methods contributed to inconsistent findings. Conclusion: The evidence linking air pollution to childhood CNS tumors remains inconclusive. Further research, with standardized exposure assessments and consideration of critical exposure windows, is needed to clarify these associations and inform public health policies to reduce environmental risks to children.

  • Open Access

    A continuous quality improvement strategy to strengthen screening practices and facilitate the routine use of intravenous iron for treating anaemia in pregnant and postpartum women in Nigeria: a study protocol

    by Ejemai Eboreime, Aduragbemi Banke-Thomas, Chisom Obi-Jeff, Yusuf Adelabu, Mobolanle Balogun, Adejoke A. Aiyenigba, Esther O. Oluwole, Opeyemi R. Akinajo, Bosede B. Afolabi

    Background: Pregnancy-related anaemia is a public health challenge across Africa. Over 50% of pregnant women in Africa get diagnosed with this condition, and up to 75% of these are caused by iron deficiency. The condition is a significant contributor to the high maternal deaths across the continent and, in particular, Nigeria, which accounts for about 34% of global maternal deaths. Whereas oral iron is the mainstay treatment for pregnancy-related anaemia in Nigeria, this treatment is not very effective given the slow absorption of the medication, and its gastrointestinal adverse effects which lead to poor compliance by women. Intravenous iron is an alternative therapy which can rapidly replenish iron stores, but fears of anaphylactic reactions, as well as several misconceptions, have inhibited its routine use. Newer and safer intravenous iron formulations, such as ferric carboxymaltose, present an opportunity to overcome some concerns relating to adherence. Routine use of this formulation will, however, require addressing misconceptions and systemic barriers to adoption in the continuum of care of obstetric women from screening to treatment. This study aims to test the options to strengthen routine screening for anaemia during and immediately after pregnancy, as well as evaluate and improve conditions necessary to deliver ferric carboxymaltose to pregnant and postpartum women with moderate to severe anaemia. Methods: This study will be conducted in a cluster of six health facilities in Lagos State, Nigeria. The study will employ continuous quality improvement through the Diagnose-Intervene-Verify-Adjust framework and Tanahashi’s model for health system evaluation to identify and improve systemic bottlenecks to the adoption and implementation of the intervention. Participatory Action Research will be employed to engage health system actors, health services users, and other stakeholders to facilitate change. Evaluation will be guided by the consolidated framework for implementation research and the normalisation process theory. Discussion: We expect the study to evolve transferable knowledge on barriers and facilitators to the routine use of intravenous iron that will inform scale-up across Nigeria, as well as the adoption of the intervention and strategies in other countries across Africa.


  • Open Access

    PB2039 PLATELET INDICES, COAGULATION BIOMARKERS AND CARDIOVASCULAR RISK FACTORS IN TREATMENT‐NAÏVE HIV‐INFECTED ADULTS IN LAGOS UNIVERSITY TEACHING HOSPITAL

    by Y. Adelabu, O. Kalejaiye, T. Adeyemo, M. Kehinde

    Background: With the use of antiretroviral therapy, the incidence of AIDS‐defining illnesses and opportunistic infections has reduced significantly, leading to increased life span of human immunodeficiency virus (HIV)‐infected individuals. Non‐infectious causes of morbidity and mortality, including cardiovascular diseases, have since emerged. Platelet indices and coagulation biomarkers are surrogate markers of cardiovascular risk in several disease conditions but their relevance in HIV infection is uncertain.Aims: The aim of this study was to evaluate platelet indices and coagulation biomarkers in untreated HIV infection and to determine their relationship with HIV disease severity and cardiovascular risk factors.Methods: A cross‐sectional study of 115 treatment‐naïve HIV‐infected adult patients attending the HIV clinic of the Lagos University Teaching Hospital and 115 age‐ and gender‐matched non‐infected adults was carried out. Socio‐demographic characteristics and history of cardiovascular risk factors were obtained from all participants, followed by body mass index (BMI) and blood pressure measurements and World Health Organization (WHO) clinical staging of the HIV‐infected subjects.Laboratory evaluation of full blood count, including platelet indices; platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW) and plateletcrit (PCT), CD4+ T lymphocyte count, fasting lipid profile, fasting plasma glucose, fibrinogen and D‐dimer levels were done for all participants.Results: The HIV‐infected group had significantly higher MPV (9.2 ± 1.0fL vs.8.5 ± 0.8 fL, P < 0.01), PDW (15.7 ± 0.4% vs.15.6 ± 0.4%, P = 0.01), PCT (0.236 ± 0.095% vs. 0.201 ± 0.051%, P < 0.01) and fibrinogen levels (250.2 ± 93.4 mg/dL vs. 193.6 ± 46.8 mg/dL, P < 0.01) than the non‐infected group. There was no significant difference in the platelet count [244 (187‐305) vs. 241 (192‐271) x109/L, P = 0.31] and D‐dimer levels [395.08 (303.23‐519.45) vs. 399.42 (316.35‐483.58) ng/mL, P = 0.96) between the HIV‐infected subjects and the non‐infected controls.The CD4+ T lymphocyte count inversely correlated with PDW (r = ‐0.248, P < 0.01) and fibrinogen levels (r = ‐0.229, P = 0.01) while the WHO clinical stage directly correlated with fibrinogen levels (r = 0.193, P = 0.04) in the HIV‐infected subjects. Lower BMI was associated with higher PLT (β = ‐0.258, P < 0.01) and PCT (β = ‐0.278, P < 0.01) while higher triglyceride (β = 0.292, P < 0.01) and HDL‐cholesterol levels (β = 0.213, P = 0.04) were associated with higher PDW in the HIV‐infected subjects. Diabetes was associated with higher fibrinogen levels in the HIV‐infected subjects (β = 0.276, P < 0.01).Summary/Conclusion: Platelet indices and fibrinogen levels are increased in HIV infection. Platelet distribution width and fibrinogen levels increase with HIV disease severity. Cardiovascular risk factors including diabetes mellitus and dyslipidaemia are associated with increase in platelet indices and fibrinogen levels in HIV infection. image

  • Open Access

    Pulmonary dysfunction among adolescents and adults with sickle cell disease in Nigeria: Implications for monitoring

    by Obianuju B Ozoh, OlufuntoO Kalejaiye, OjiebunE Eromesele, YusufA Adelabu, Sandra K Dede, FolasadeO Ogunlesi

    Background: Pulmonary complications of sickle cell disease (SCD) contribute to excess morbidity and mortality. The burden of pulmonary dysfunction among Nigerians with SCD has not been well elucidated. OBJECTIVES: The objectives of this study are to describe the frequency and pattern of spirometry abnormalities in SCD and to explore the association between pulmonary dysfunction and selected parameters. METHODS: A cross-sectional study among adolescents and adults with SCD attending a University Teaching Hospital and healthy age- and gender-matched controls. Respiratory symptoms, oxygen saturation, spirometry, complete blood counts, and fetal hemoglobin (Hb) were measured. RESULTS: A total of 245 participants with SCD and 216 controls were included in the study. Frequency of respiratory symptoms was similar between the two groups. The median forced expiratory volume 1 (FEV1), forced vital capacity (FVC), and the FEV1/FVC were significantly lower in SCD as compared to controls (P = 0.000 in all instances). The frequency of abnormal pulmonary patterns was higher in SCD as compared to controls with abnormal spirometry pattern in 174 (71%) and 68 (31.5%) of participants with SCD and controls, respectively (P = 0.000). The suggestive of restrictive pattern was predominant (48% vs. 23%), but obstructive (11.8% vs. 7.4%) and mixed patterns (11% vs. 0.9%) were also found among SCD versus controls. Hb concentration was positively associated with FEV1 and FVC, whereas white cell count and age were negatively associated with FVC and FEV1, respectively. CONCLUSION: There is a high burden of pulmonary dysfunction in SCD among Nigerians which may be related to the severity of disease. There is a need for further research to explore the effectiveness of potential interventions so as to harness the benefits from monitoring and early detection.